Licensed Practical Nurse in Hampton, VA Accepting Medicare

9 Licensed Practical Nurse nurses found. Showing 1 - 9

Janette Lorenza Parker, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 110 Coliseum Xing # 188, Hampton, VA 23666 Phone: 757-751-7832

Candice Cuble, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 309 Big Bethel Rd, Hampton, VA 23666 Phone: 757-776-1340

Porsche Silver, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 210 Marsh Loop, Hampton, VA 23666 Phone: 757-675-3285

Mrs. Shenelle Marie Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961

Kimberly Rena Clanton, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961

Patricia Crooms, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 124 Barksdale Rd, Hampton, VA 23669 Phone: 757-240-1496

Tanisha Banks-cooper, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1203 N Mallory St, Hampton, VA 23663 Phone: 757-254-6026

Luvenia Lea Broadnax Ezell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1126 Big Bethel Rd, Hampton, VA 23666 Phone: 757-776-5843

Mr. Michael George Henry, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961    Fax: 757-726-6036

News Archive

Boston Scientific receives FDA approval for Innova Vascular Self-Expanding Stent System

Boston Scientific Corporation has received Food and Drug Administration approval for the Innova Vascular Self-Expanding Stent System, an advanced treatment option for patients with narrowing or blockages in the superficial femoral artery (SFA) or proximal popliteal artery (PPA).

Raptor initiates dosing in DR Cysteamine Phase 2 clinical trial for Huntington's Disease

Raptor Pharmaceutical Corp., today announced that the first patient has been dosed in its Phase 2 clinical trial of DR Cysteamine for the potential treatment of Huntington's Disease. The Phase 2 clinical trial is being conducted under a previously announced collaboration agreement with The Centre Hospitalier Universitaire d'Angers ("CHU d'Angers"), which has commenced enrolling patients at eight clinical sites throughout France.

State highlights: New Calif. health laws signed; Mass. judge considers partners deal

A selection of health policy stories from California, Massachusetts, New York, the District of Columbia, Minnesota and Kansas.

Scientists develop nitric oxide-releasing cloth to make therapeutic socks for diabetes patients

Scientists in Texas are reporting development of a first-of-its-kind cloth that releases nitric oxide gas - an advance toward making therapeutic socks for people with diabetes and a wrap to help preserve organs harvested for transplantation. The study is in ACS' Chemistry of Materials, a bi-weekly journal.

We are at the very beginning of 'gene finding' for alcohol response

Alcoholism is a complex, genetically influenced disorder. Multiple phenotypes – measurable and/or observable traits or behavior – contribute to the risk of developing alcoholism, particularly disinhibition, alcohol metabolizing patterns, and a low level of response (LR) to alcohol.

Read more Medical News

› Verified 2 days ago